Jacqueline Watchmaker, MD

U.S. Dermatology Partners Chief Executive Officer Paul Singh stated, “We are pleased to welcome Dr. Watchmaker back to Arizona where we know she will make an excellent addition to our CALM Scottsdale and Phoenix teams.”

SCOTTSDALE, Ariz. (PRWEB)
November 03, 2021

U.S. Dermatology Partners is pleased to welcome Board-Certified Dermatologist Dr. Jacqueline Watchmaker to their CALM Scottsdale and Phoenix 32nd locations.

Dr. Jacqueline Watchmaker is a Board-Certified Dermatologist who practices general and cosmetic dermatology. Dr. Watchmaker helps patients with all aspects of their skin including rashes, skin cancers, acne, skin aging, cosmetic procedures, and more. She feels that the most rewarding part of her job is sharing knowledge with her patients so that as a team the patient can partner in how to best treat their skin condition.

Dr. Watchmaker won numerous awards and honors throughout her medical training at Medical College of Wisconsin, where she attended medical school, and Boston University, where she completed her dermatology residency. During medical school, she was elected to the prestigious Alpha Omega Alpha Honor Society. During residency, she was selected as the top intern and also served as the Director of Resident Education during her second year of training. During her final year of residency, she was selected as the Chief Resident for her program.

Following her medical training, Dr. Watchmaker furthered her education with a fellowship at the renowned Skincare Physicians in Chestnut Hill, Massachusetts where she focused on cosmetic dermatology and laser medicine. There, she developed expertise in the use of lasers for the treatment of a variety of skin conditions and cosmetic procedures. During her fellowship, she trained with dermatologists who are leaders in the field and worked on clinical trials which are advancing the treatment of dermatologic conditions. Through this work, she developed an expertise in the use of injectable fillers, neuromodulators (such as Botox), lasers, and other energy-based devices to treat a wide variety of medical and cosmetic conditions including scars, birthmarks, rosacea, acne, cellulite, melasma, hair loss, and aging skin.

Dr. Watchmaker has been invited to present at national conferences including the American Academy of Dermatology, the American Society for Dermatologic Surgery, and the American Society for Laser Medicine and Surgery. She has also written multiple book chapters and contributed research papers to peer-reviewed medical journals.

Dr. Watchmaker grew up in Wisconsin and trained in Boston but has adopted Arizona (where she has many family members) as her home. Outside of practicing dermatology, she enjoys spending time with her husband and family (including her twin sister), hiking, cooking, and taking barre classes. She is thrilled to be a part of the U.S. Dermatology Partners family and looks forward to providing her patients with exceptional care at the CALM Scottsdale location.

U.S. Dermatology Partners Chief Executive Officer Paul Singh stated, “We are pleased to welcome Dr. Watchmaker back to Arizona where we know she will make an excellent addition to our CALM Scottsdale and Phoenix teams.”

Dr. Jacqueline Watchmaker treats patients in CALM Scottsdale and Phoenix 32nd and is accepting new patients. To schedule an appointment, call 480-591-3500.

About U.S. Dermatology Partners

As one of the largest dermatology practices in the country, U.S. Dermatology Partners patients not only have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network but also benefit from the practice’s strong dermatology subspecialty thought leaders and medical advisory board. To be the best partner to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.

Share article on social media or email:

“It is such an honor to once again be recognized by “The Park Record” as Park City’s Best Plastic Surgeon. My goal is to always help my patients look and feel their best by designing effective treatment plans to achieve aesthetic goals,” says Dr. Eric Cerrati

SALT LAKE CITY (PRWEB)
November 03, 2021

For two years in a row, the Park City, Utah, community has voted for Dr. Eric Cerrati as one of the city’s Best Plastic Surgeons in the local magazine’s 2021 People’s Choice edition. Dr. Eric Cerrati is a double board-certified facial plastic surgeon and an expert in aesthetic and reconstructive facial plastic surgery. In addition to running his thriving practice, Dr. Cerrati is also an assistant professor and director at the University of Utah’s Department of Facial Plastic & Reconstructive Surgery. His plastic surgery clinics are state-of-the-art, offering a full range of cutting-edge facial cosmetic and reconstructive procedures, including an array of non-surgical options as well as pediatric reconstructive plastic surgery. Dr. Cerrati’s expertise includes facelift, rhinoplasty, endoscopic browlift, blepharoplasty, facial fillers, Mohs reconstruction, scar revision and pediatric facial plastic surgery for vascular and congenital anomalies. Dr. Cerrati and his team of caring medical professionals are second to none in their field and are well-deserving of this impressive accolade.

Link to publication: https://edition.pagesuite-professional.co.uk/html5/reader/production/default.aspx?pubname=ParkRecord%20SpecialSections&edid=4ede4e55-7443-4797-8619-bd70a63096a0

“It is such an honor to once again be recognized by “The Park Record” as Park City’s Best Plastic Surgeon. My goal is to always help my patients look and feel their best by designing effective treatment plans to achieve aesthetic goals,” says Dr. Eric Cerrati

More about Dr. Eric Cerrati:

Dr. Eric Cerrati received his medical degree from the Medical University of South Carolina in Charleston, SC. His post-doctoral training included a 5-year residency in otolaryngology-head and neck surgery at NYU. Dr. Cerrati spent a significant amount of time working with Dr. Milton Waner, the founder of the Vascular Birthmark Institute of New York. This provided him with unique training in pediatric facial plastic surgery, addressing the rarest congenital anomalies. Following his residency, he also completed a prestigious fellowship at the Facial Plastic Surgery Center in Chicago. As a highly credentialed leader in his field, Dr. Cerrati speaks at medical conferences and is a contributor to many medical journals and textbooks. In addition to treating his patients, Dr. Cerrati also served as the official facial plastic surgeon to the Utah Jazz, U.S. Ski and Snowboard Association, U.S. Speedskating, U.S. Bobsled and Skeleton Federation and the International Olympic and Paralympic Medical Committees.

If you would like to get more information about Dr. Eric Cerrati or his plastic surgery practice locations in Salt Lake City and South Jordan, Utah, please visit http://www.drericcerrati.com or call (801) 585-3223.

Share article on social media or email:

In honor of #BreastCancerAwarenessMonth KoreHealth did its part by launching a social media fundraiser with the National Breast Cancer Foundation.

KoreHealth believes no one should have to navigate breast cancer alone. We’re stronger together! So, drop down, knock out some push-ups, and let’s rally together and show some support for our friends, loved ones, and everyone else out there fighting! #KHPushUpChallenge

NEW YORK (PRWEB)
November 03, 2021

In honor of #BreastCancerAwarenessMonth this October, KoreHealth, a leader in health and fitness innovation, is doing its part by launching a social media fundraiser with the National Breast Cancer Foundation.

The horrors of breast cancer are all too familiar to so many of us. We’ve all known someone who’s been diagnosed with or lost a battle with breast cancer. It’s affected wives, sisters, mothers, grandmothers, and so many more.

That’s why all month long, KoreHealth asked its followers to show their support for all those fighting via the #KHPushUpChallenge.

Here’s how it worked: KoreHealth challenged all of its followers to film themselves completing as many push ups as they can in a row, post to their social media and challenge the rest of their friends and followers to do the same! For every #KHPushUpChallenge participant KoreHealth will be donated $1 to the National Breast Cancer Foundation and match any individual donation made towards the fundraiser.

Star-studded participation included founder Jason Manly, Edmen Shahbazyan, Rampage Jackson Jr., AJ McKee, Rachael Cummins, among many others.

KoreHealth aimed to spread awareness and hope for all those affected by Breast Cancer. The statistics are alarming and hit all too close to home for so many.

There are over 2.8M breast cancer survivors living in the US

85% of diagnoses occur in women with no family history of breast cancer

1 in 8 women will develop breast cancer during their lifetime

1 in about 833 men will develop breast cancer in their lifetime

As vital as it is to find a cure, the first step is prevention. So, encourage the women in your life to get regular mammogram screenings and get educated about breast cancer warning signs and symptoms. The sooner breast cancer is diagnosed, the easier it is to treat!

No one should have to navigate breast cancer alone. We’re stronger together! So, drop down, knock out some push-ups, and let’s rally together and show some support for our friends, loved ones, and everyone else out there fighting!

KoreHealth encourages all too keep spreading awareness past October and continue to keep fighting for a cure!

Share article on social media or email:

The Los Angeles-based agency helps build families nationwide and internationally.

Well-qualified surrogacy agencies are accustomed to working around restrictive surrogacy laws.

LOS ANGELES (PRWEB)
November 02, 2021

An October 8 article on WOTV 4 reports on a Grand Rapids couple’s struggle with restrictive surrogacy laws in Michigan. In their interview, the couple says they were shocked to learn that compensated surrogacy is illegal in their home state and that barriers would prevent their biological child from legally being recognized as their own without going through an adoption process – even if they were to go through an unpaid surrogate. The article also references another Michigan couple who was forced to leave their home state to work with a surrogacy agency based elsewhere in the U.S. in order to have a successful childbirth. Los Angeles-based Global Surrogacy Services says that well-qualified surrogacy agencies are accustomed to working around restrictive surrogacy laws, giving intended parents the hope of one day expanding their families without having to worry about potential legal concerns.

Global Surrogacy Services says navigating through the sea of bureaucracy and legal matters surrounding surrogacy is, unsurprisingly, one of the hardest parts of the process—especially if multiple countries are involved, as this requires the help of legal experts familiar with the relevant jurisdictions. Additionally, the agency notes that issues of citizenship, legal guardianship, and more can all affect the process, making it incredibly difficult for intended parents to sift through the legality of surrogacy on their own. Even acquiring the services of the right kind of lawyers can be difficult for people who are not experts on the process.

Intended parents who go through an agency, however, can generally leave much of the legal process to the agency’s team of gestational surrogacy experts instead. Global Surrogacy Services says this allows intended parents to focus their attention on more traditional pre-natal concerns, like building a nursery and learning about how to care for their baby.

Global Surrogacy Services says that the resources available to an established agency can facilitate a healthy pregnancy from the start of the matchmaking process through post-pregnancy care for the surrogate. The agency says that in doing so, the chances for complications are dramatically reduced. Intended parents can trust that their surrogate and the growing baby will be happy and healthy, while surrogates can trust that all their medical needs will be well taken care of.

Global Surrogacy Services says above all, the point of the agency is to ensure a successful pregnancy and happy intended parents. Readers can learn more about Global Surrogacy Services and the surrogacy process by visiting the agency’s website at https://globalsurrogacyservices.com/ or calling (800) 355-2009.

Share article on social media or email:

Sister Helen Amos, RSM, Executive Chair, Board of Trustees, Mercy Health Services

“It is a great honor to be recognized with an award named for such a beloved Baltimore icon and masterful politician and public servant, William Donald Schaefer…” — Sister Helen Amos, RSM

BALTIMORE (PRWEB)
November 02, 2021

The University of Baltimore Schaefer Center for Public Policy has announced that Sister Helen Amos, RSM, Executive Chair, Mercy Health Services Board of Trustees, will receive the 2020 William Donald Schaefer Award as part of virtual ceremonies to be held today, Tuesday, Nov. 2nd, 2021 (the late Mr. Schaefer’s 100th birthday).

Sister Helen was to have been recognized in April 2020 as part of the William Donald Schaefer Policy Conference and Award Ceremony at The University of Baltimore, but the event was cancelled due to the COVID-19 pandemic. Honoring the 50-year public service legacy of Mr. Schaefer, the conference explores the traits of legendary, transformational leaders and discusses how these traits can be cultivated in public sector leaders today.

The William Donald Schaefer Award celebrates the contributions of the honoree to effective government and lifelong commitment and service to the well-being of the citizens of Maryland. Award recipients are chosen based on a variety of factors, including their efforts to better the community, aid the region’s most vulnerable populations, and taking steps to improve the lives of fellow Marylanders.

Previous honorees have included Congressman Elijah Cummings (2015); Dr. Nancy Grasmick (2016), former Maryland State Superintendent of Schools; The Honorable Carolyn Colvin (2017), former Acting Commissioner, Social Security Administration, and U.S. Senator Paul Sarbanes (2018).

“It is a great honor to be recognized with an award named for such a beloved Baltimore icon and masterful politician and public servant, William Donald Schaefer, who’s years of service spanned nearly three decades as Baltimore mayor, Maryland governor and state comptroller,” Sister Helen said.

Sister Helen Amos, RSM, has more than 35 years’ experience in the fields of education and health care administration. After working as a teacher in Georgia, Sister Helen arrived in Baltimore to take a position as Registrar for Mount Saint Agnes College where she had earned her Bachelor of Arts degree in Mathematics in 1962. Sister Helen would later take on administrator duties with the Sisters of Mercy of the Union and the Archdiocese of Baltimore. Before coming to Mercy, Sister Helen served as President of the Sisters of Mercy of the Union in Silver Spring, Maryland from 1984 to 1991.

Sister Helen and the leadership team of Mercy Health Services are responsible for the development and implementation of numerous programs at Mercy, including the creation of The Center for Women’s Health & Medicine and its flagship programs in gynecologic oncology and breast cancer diagnosis and treatment; “The Woman’s Doctor” program on WBAL-TV; and Mercy’s network of specialty and primary care physicians.

Sister Helen serves on the board and is President of Mercy Ridge, a continuing care retirement community in Timonium, MD. She is currently a board member of Mercy Health Ministry, St. Louis, Missouri; the Downtown Partnership (past chair) and the Downtown Management District Authority of Baltimore City; Cristo Rey Jesuit High School; Mercy High School; and the Board of Financial Administration of the Archdiocese of Baltimore.

The University of Baltimore Schaefer Center for Public Policy was established in 1985 in honor of then-Mayor of Baltimore City William Donald Schaefer. The Center provides non-partisan applied research, technical assistance, and professional development services to government and nonprofit organizations.

Founded in 1874 by the Sisters of Mercy in downtown Baltimore, Maryland, Mercy Medical Center is a university-affiliated, Catholic hospital with a national reputation for women’s health, orthopedics, surgical oncology, and other medical disciplines. Mercy is home to the nationally renowned Weinberg Center for Women’s Health and Medicine, and the 20-story, +$400 million Mary Catherine Bunting Center. For more information, visit Mercy online at http://www.mdmercy.com; MDMercyMedia on Facebook and Twitter, or call 1-800-M.D.-Mercy.

-30-

Share article on social media or email:

2022 Caravan Health Accountable Care Symposium

“The annual event is our opportunity to recognize our ACO partners for persevering and innovating throughout the difficult time of the COVID-19 public health emergency, and to focus on new ways to better serve patients,” said Tim Gronniger, Caravan Health CEO and President.

KANSAS CITY, Mo. (PRWEB)
November 02, 2021

Today, Caravan Health announced early bird registration for its 6th Accountable Care Symposium. The two-day symposium is the nation’s premier event for the value-based payment community and will be held in San Diego, California at the Hilton Bayfront on May 25 and 26, 2022. Virtual participation options will be available.

The highly anticipated event brings together health care leaders seeking to kickstart or improve their population health strategy and maximize opportunities in value-based payment models, including 340B drug discounts. Participants will hear from Caravan’s subject matter experts, experienced value-based care participants, and nationally recognized thought leaders to gain first-hand knowledge about clinical best practices and to learn about the technological tools that streamline information flow. Participants will have the opportunity to meet and learn from each other during several networking opportunities.

“The theme for the Symposium is ‘Shaping the Future of Patient Care’. The annual event is our opportunity to recognize our ACO partners for persevering and innovating throughout the difficult time of the COVID-19 public health emergency, and to focus on new ways to better serve patients,” said Tim Gronniger, Caravan Health CEO and President.

For those taking advantage of early bird pricing, registration fees for in-person attendance starts at $799. Continuing education credits are available. Registration and other information are available here for the 2022 Accountable Care Symposium.

Caravan is calling for presentation proposals on topics such as HCC capture, technology tools, targeting high-risk patient groups, physician engagement, and team-based care. Proposals can be submitted at http://www.caravanhealth.com/symposium by January 5.

About Caravan Health:

Caravan Health creates sustainable methodologies for health systems to excel in value-based payment models. Caravan Health works with hospitals, health systems, and health care providers who partner in ACOs to improve patient outcomes while lowering the overall cost of care. Through its proven population health methodology and award-winning technology, Caravan-supported ACOs have led the nation in the Medicare Shared Savings Program, saving Medicare $476 million since 2015. In 2020, 100% of Caravan’s Collaborative ACOs earned shared savings and achieved an average 99% MIPS score and 97% quality score. With Caravan Health, now the numbers work.  For more information visit http://www.caravanhealth.com.

Share article on social media or email:

We are reimagining the customer experience by delivering tailored, technology-forward solutions with a mission focus and a people-first culture at the center of everything we do.

FALLS CHURCH, Va. (PRWEB)
November 02, 2021

Cognosante’s Founder and CEO Michele Kang today announced the launch of CognoConnected – the company’s dedicated customer experience (CX) business sector. Cognosante has a long-standing legacy of providing innovative CX solutions across some of the most vital federal, state, and commercial programs, supporting the health and safety of Americans. The dedicated business sector focuses the company’s commitment on ensuring customers achieve successful CX mission outcomes.

CognoConnected transforms the way people connect, engage, and interact with vital services and programs by delivering solutions in four key areas: access to information, customer engagement, CX optimization, and automation and analytics.

“Our goal is to support our customers’ missions by creating customer experiences that put people first,” said Kang. “As people’s CX expectations are increasingly influenced by experiences in the consumer market, providing exceptional customer service for public programs requires a sustained focus on people, processes, and innovation.”

CognoConnected President James Gordon added, “I’m excited to lead our CognoConnected business sector to market. We are reimagining the customer experience by delivering tailored, technology-forward solutions with a mission focus and a people-first culture at the center of everything we do.”

With CognoConnected, Cognosante is helping agencies transform their CX ecosystems and connect with the people they serve. As a people-centric organization and two-time certified Great Place to Work™, the company is focused on recruiting and retaining top talent in the CX market, including customer service representatives, case managers, and quality analysts by investing in training and development, and creating an environment in which customer experience employees can thrive and build a rewarding career.

About Cognosante

Cognosante is a mission-driven technology company delivering innovative and transformative solutions to Federal, state, and local governments. We are dedicated to supporting the health, safety, and well-being of Americans who serve the nation and those who need it most. The company has more than a decade of experience working with states and the Federal government to improve access to care and address social determinants of health by developing, managing, and executing large multi-faceted technology and customer experience (CX) solutions. Its expertise includes Medicaid, Medicare, military and Veterans’ health, the health insurance marketplace, data standards and analytics, cybersecurity, biometrics, and modular systems development and integration. Visit http://www.cognosante.com for more information.

Share article on social media or email:

The Society for Immunotherapy of Cancer’s (SITC) 36th Anniversary Annual Meeting (SITC 2021)

MILWAUKEE (PRWEB)
November 02, 2021

The Society for Immunotherapy of Cancer (SITC) invites you to attend the virtual press briefing of the society’s 36th Anniversary Annual Meeting (SITC 2021) beginning at 12:30 p.m. EST on Wednesday, Nov. 10, 2021.

The abstracts selected for the press briefing represent an array of the top advances in cancer immunotherapy research. Regular and late-breaking abstracts are embargoed until 8 a.m. EST, Nov. 9, 2021. Data shared during the presentation is embargoed until that date unless otherwise stated during the press briefing. For more information, please review the SITC 2021 Media Policy.

The presentations scheduled to occur during the press briefing are listed in order below:

Abstract # 389: Phase II of CD40 agonistic antibody sotigalimab (APX005M) in combination with nivolumab in subjects with metastatic melanoma with confirmed disease progression on anti-PD-1 therapy

Presenter: Harriet Kluger, MD – Yale University School of Medicine

Abstract # 169: Off-the-shelf, engineered iPSC-derived NK cells mediate potent cytotoxic activity against primary glioblastoma cells and promote durable long-term survival in vivo

Presenter: Jeffrey S. Miller, MD – University of Minnesota

Abstract # 347: KEYNOTE-365 cohort C: pembrolizumab + enzalutamide in patients with abiraterone acetate–pretreated metastatic castration-resistant prostate cancer (mCRPC)—Data after minimum of 22 months of follow-up

Presenter: Leonard J. Appleman, MD, PhD – University of Pittsburgh Medical Center

Abstract # 417: Phase 3 study of pembrolizumab + belzutifan + lenvatinib or pembrolizumab/quavonlimab + lenvatinib versus pembrolizumab + lenvatinib as first-line treatment for advanced renal cell carcinoma

Presenter: Toni K. Choueiri, MD – Dana-Farber Cancer Institute and Harvard Medical School

Abstract # 453: Personalized DNA neoantigen vaccine (GNOS-PV02) in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma

Presenter: Mark Yarchoan, MD – Johns Hopkins Sidney Kimmel CCC

Abstract # 350: Phase 2 trial of a DNA vaccine with pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)

Presenter: Douglas G. McNeel, MD, PhD – Carbone Cancer Center, University of Wisconsin-Madison

Abstract # 438: A phase 1 trial of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer

Presenter: Sara I. Pai, MD, PhD – Massachusetts General Hospital

Abstract # 407: A Phase 1b KEYNOTE-B79 trial evaluating non-gene edited allogeneic CAR T-cells, CYAD-101, post FOLFOX preconditioning, followed by pembrolizumab, in refractory metastatic colorectal cancer patients

Presenter: Anne Flament, MD – Celyad Oncology

Abstract # 278: Systematic review and meta-analysis evaluating the impact of antibiotic use on clinical outcomes of non-small-cell lung cancer patients treated with immune checkpoint inhibitors

Presenter: Athéna Crespin, Engineer – Da Volterra

Abstract # 341: A phase Ib expansion cohort of pixatimod plus nivolumab in previously treated, microsatellite stable metastatic colorectal cancer (MSS mCRC)

Presenter: Charlotte Lemech, MBBS BSc(med) FRACP MD(res)– Scientia Clinical Research Pty Ltd.

ADDITIONAL DETAILS:

Participating members of the media will have the opportunity to submit questions via chat for up to three minutes following each presentation. To attend this press briefing, you must register as a member of the press for SITC 2021. To register, please visit https://www.sitcancer.org/2021/press/press-registration. After registration is confirmed, you will receive instructions for the briefing. For more information regarding SITC 2021, please visit the Annual Meeting website at http://www.sitcancer.org/2021.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.

Share article on social media or email: